Cipla gets final approval from USFDA for multiple sclerosis drug
Drug major Cipla on Friday said it has received final approval from the US health regulator for
Read moreDrug major Cipla on Friday said it has received final approval from the US health regulator for
Read moreLiving up to its moniker of a defensive bet, the Rs 2.8 lakh crore Indian pharmaceutical sector
Read more